查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941213

神经刺激设备市场报告：按刺激类型、设备类型、应用、最终用户和地区划分（2026-2034 年）

Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球神经刺激设备市场规模达105亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到233亿美元，2026年至2034年的复合年增长率为8.83%。推动市场成长的关键因素包括人口老化和医疗费用支出增加、非侵入性或微创神经刺激技术的发展，以及政府和私人医疗保险公司报销政策的改善。

神经刺激设备是一种先进的医疗技术，旨在调节和影响人体内神经活动。这些设备透过向神经系统的特定区域传递电脉衝或磁脉衝来发挥作用，旨在缓解各种神经系统疾病和慢性病症。它们提供了一种前景广阔的非侵入性或微创治疗方法，有望改善患者的生活质量，并为治疗各种神经系统疾病开闢新的可能性。神经刺激设备主要分为两大类：深部脑部刺激（DBS）和脊髓刺激。 DBS 使用植入特定脑区的电极来调节异常神经讯号，治疗帕金森氏症、自发性震颤和肌张力不全症等疾病。

人口老化正在推动全球市场的发展。随着老年人口的增长，对用于治疗相关疾病的神经刺激设备的需求预计将会上升。此外，非侵入性或微创神经刺激技术的发展正在扩大潜在患者群体，因为与传统手术相比，这些技术通常风险更低、恢復期更短。同时，一些地区政府和私人医疗保险公司改善的报销政策也使患者更容易获得神经刺激治疗，进一步推动了市场成长。此外，正在进行的研究和临床试验也为神经刺激设备的安全性和有效性提供了更多证据。这些研究的积极结果正在增强医疗专业人员和患者对该技术的信任。此外，不断增长的医疗费用支出也支持了市场解决方案的成长，因为神经刺激设备为慢性病管理提供了一种经济有效的方法，从而推动了其应用。

神经刺激设备市场趋势及驱动因素：

神经系统疾病盛行率不断上升

神经系统疾病，例如帕金森氏症、癫痫、慢性疼痛和忧郁症，影响全球数百万人，并给医疗保健成本带来沉重负担。对于对传统疗法无反应或出现严重副作用的患者而言，神经刺激设备提供了极具前景的解决方案。深部脑部刺激（DBS）在治疗帕金森氏症等运动障碍方面展现出显着疗效，推动了对这类设备的需求。此外，慢性疼痛发生率的上升，尤其是在人口老化和久坐生活方式的影响下，也促使人们对脊髓刺激（SCS）设备的需求日益增长，这类设备能够在缓解疼痛的同时显着减少对药物的依赖。随着各国政府和医疗机构将改善患者预后作为优先事项并寻求创新解决方案，预计对神经刺激设备的需求将稳定成长。

神经刺激技术的持续进步

持续的研发工作正推动更先进、更具针对性的神经刺激设备的研发。创新技术包括更小巧、更精准的电极、更长的电池寿命，以及整合封闭回路型系统，可根据患者的即时需求自动调节刺激参数。这些进步提高了治疗效果，减少了副作用，并提升了患者的舒适度。此外，微创植入神经刺激设备技术的开发使其能够应用于更广泛的患者群体，使治疗更易于获得，并吸引更多患者和医疗服务提供者。随着技术的不断发展，神经刺激设备将变得更加高效和适应性更强，从而进一步加速其普及和市场渗透。

提高人们对神经调控疗法的认识与接受度

随着越来越多的临床证据证实神经刺激设备在治疗各种神经系统疾病的有效性，医疗专业人员也越来越倾向于向患者推荐这些治疗方法。此外，患者权益倡导组织和宣传宣传活动在教育大众了解神经刺激疗法的潜在益处方面发挥关键作用，从而提高了患者对该疗法的接受度。一些患者透过神经刺激设备显着改善了生活质量，他们的成功案例进一步提升了人们对这些治疗方法的积极认知。随着人们对神经调控技术的信心不断增强，预计对这些设备的需求将会增加，从而推动市场扩张。此外，医疗机构、研究人员和设备製造商之间的合作，旨在提高公众认知并确保合理使用，也将有助于神经刺激设备市场的持续成长。

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章 引言

第五章：全球神经刺激设备市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 按刺激类型分類的市场区隔

  • 内部刺激
  • 外部刺激

第七章 按设备类型分類的市场区隔

  • 脊髓刺激（SCS）装置
  • DBS（深部脑部刺激）装置
  • 荐椎神经刺激（SNS）装置
  • 迷走神经刺激（VNS）装置
  • 胃电刺激（GES）装置
  • 经皮电神经刺激设备
  • 经颅磁刺激装置
  • 其他的

第八章 按应用分類的市场细分

  • 疼痛管理
  • 癫痫
  • 自发性震颤
  • 尿失禁和粪便失禁
  • 忧郁症
  • 肌张力不全症
  • 帕金森氏症
  • 其他的

第九章 依最终用户分類的市场细分

  • 復健中心
  • 医院
  • 诊所
  • 其他的

第十章 按地区分類的市场细分

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十一章 SWOT 分析

第十二章 价值链分析

第十三章 波特五力分析

第十四章 物价指数

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Biocontrol Medical
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • Medtronic Inc.
    • Neuronetics Inc.
    • Neuropace Inc.
    • Neurosigma Inc.
    • Nevro Corporation
    • ST. Jude Medical Inc.
    • Synapse Biomedical Inc.
Product Code: SR112026A1892

The global neurostimulation devices market size reached USD 10.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.3 Billion by 2034, exhibiting a growth rate (CAGR) of 8.83% during 2026-2034. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.

Neurostimulation devices are advanced medical technologies designed to modulate and influence neural activity within the human body. These devices work by delivering electrical or magnetic impulses to specific regions of the nervous system, aiming to alleviate various neurological conditions and chronic disorders. They offer a promising non-invasive or minimally invasive therapeutic approach, enhancing the quality of life for patients and potentially opening up new avenues for treating various neurological disorders. The two primary types of neurostimulation devices are deep brain stimulation and spinal cord stimulation. DBS involves implanting electrodes into targeted brain areas to regulate abnormal neural signals and treat conditions such as Parkinson's disease, essential tremor, and dystonia.

The growing aging population is driving the global market. As the elderly population grows, the demand for neurostimulation devices to manage these conditions is likely to rise. Moreover, the development of non-invasive or minimally invasive neurostimulation technologies has expanded the potential patient pool, as these options often offer reduced risks and quicker recovery times compared to traditional surgical procedures. Besides, improved reimbursement policies by government and private health insurers in some regions have made neurostimulation treatments more accessible to patients, encouraging market growth. Also, ongoing research and clinical trials have provided additional evidence for the safety and efficacy of neurostimulation devices. Positive results from these studies have increased confidence in the technology among medical professionals and patients. Furthermore, the rising healthcare expenditure is supporting the growth of market solutions as neurostimulation devices offer a cost-effective approach to managing chronic conditions, which has driven their adoption.

Neurostimulation Devices Market Trends/Drivers:

Increasing Prevalence of Neurological Disorders

Neurological conditions such as Parkinson's disease, epilepsy, chronic pain, and depression affect millions of people worldwide, leading to significant healthcare burdens. Neurostimulation devices offer a promising solution for patients who are refractory to conventional treatments or experience severe side effects. Deep brain stimulation (DBS) has demonstrated remarkable efficacy in managing movement disorders, such as Parkinson's disease, thereby augmenting the demand for these devices. Additionally, the escalating incidence of chronic pain, particularly due to aging populations and sedentary lifestyles, fuels the need for spinal cord stimulation (SCS) devices to provide pain relief without relying heavily on medications. As governments and healthcare organizations prioritize improved patient outcomes and seek innovative solutions, the demand for neurostimulation devices is expected to grow steadily.

Continual Advancements in Neurostimulation Technologies

Continuous research and development efforts have led to the creation of more sophisticated and targeted neurostimulation devices. Innovations include smaller and more precise electrodes, improved battery life, and the integration of closed-loop systems that can automatically adjust stimulation parameters based on real-time patient needs. These advancements translate to enhanced treatment outcomes, reduced side effects, and increased patient comfort. Moreover, the development of minimally invasive procedures for implanting neurostimulation devices has expanded their applicability to a broader patient population, making the treatments more accessible and appealing to both patients and healthcare providers. As technology continues to evolve, neurostimulation devices will likely become even more efficient and adaptable, further impelling their adoption and market penetration.

Growing Awareness and Acceptance of Neuromodulation Therapies

As more clinical evidence supports the effectiveness of neurostimulation devices in treating various neurological disorders, medical practitioners increasingly recommend these therapies to their patients. Additionally, patient advocacy groups and awareness campaigns have played a crucial role in educating individuals about the potential benefits of neurostimulation, leading to greater patient acceptance of these treatments. The success stories of patients who have experienced significant improvements in their quality of life through neurostimulation devices have further contributed to the positive perception of these therapies. As trust in neuromodulation grows, the demand for these devices is expected to increase, fuelling the market expansion. Furthermore, collaborations between healthcare organizations, researchers, and device manufacturers to spread awareness and ensure appropriate usage will contribute to the sustained growth of the neurostimulation devices market.

Neurostimulation Devices Industry Segmentation:

Breakup by Stimulation Type:

  • Internal Stimulation
  • External Stimulation

Internal stimulation devices form a significant segment within the neurostimulation market, characterized by their implantable nature. These devices are surgically placed within the body to deliver targeted electrical or magnetic stimulation directly to specific neural structures. The demand for internal stimulation devices is driven by their efficacy in managing complex neurological disorders that do not respond adequately to medications or other treatments. The ability to precisely target neural circuits while providing reversible and adjustable stimulation parameters enhances treatment outcomes, leading to improved patient quality of life.

On the other hand, external stimulation devices represent another substantial segment in the neurostimulation market, characterized by their non-invasive or minimally invasive nature. These devices are applied externally to the body's surface, delivering stimulation without the need for surgical implantation.

Breakup by Device Type:

  • SCS (Spinal Cord Stimulation) Devices
  • DBS (Deep Brain Stimulation) Devices
  • SNS (Sacral Nerve Stimulation) Devices
  • VNS (Vagus Nerve Stimulation) Devices
  • GES (Gastric Electrical Stimulation) Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Others

SCS (spinal cord stimulation) dominates the market

SCS involves the implantation of electrodes along the spinal cord, where electrical impulses are delivered to modulate pain signals and provide relief for chronic pain conditions. The minimally invasive nature of the procedure offers numerous benefits, including shorter recovery times and reduced risks compared to invasive surgeries. Additionally, the customizable nature of SCS allows for individualized programming to target specific pain areas, tailoring treatment to meet each patient's unique needs. Moreover, continual advancements in SCS technology have led to more sophisticated devices with improved battery life, smaller implants, and enhanced programming capabilities, providing greater patient comfort and long-term sustainability. The focus on patient-centered care and shared decision-making has led to an increased emphasis on personalized pain management plans. Spinal cord stimulation, with its individualized programming capabilities, aligns well with this patient-centric approach, fueling its adoption in pain management strategies.

Breakup by Application:

  • Pain Management
  • Epilepsy
  • Essential Tremors
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Parkinson's Disease
  • Others

Pain management dominates the market

Neurostimulation devices designed for pain management offer a promising alternative, particularly spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies work by delivering controlled electrical impulses to target nerves, modulating pain signals, and thereby reducing the perception of pain. Pain management through neurostimulation has demonstrated remarkable efficacy in various chronic pain conditions, including neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Additionally, the advancements in neurostimulation technology have led to more personalized and precise pain management solutions, allowing for tailored treatment strategies based on individual patient needs.

Breakup by End-User:

  • Rehabilitation Centers
  • Hospitals
  • Medical Clinics
  • Others

Hospitals dominates the market

Hospitals play a central role in the diagnosis, treatment, and management of various neurological and chronic disorders, which often require neurostimulation therapies as part of the treatment plan. Hospitals have access to multidisciplinary teams of medical professionals, including neurologists, neurosurgeons, pain specialists, and anesthesiologists, who collaborate to provide comprehensive care to patients requiring neurostimulation therapies. Additionally, they are equipped with state-of-the-art operating rooms and facilities that meet stringent regulatory standards, ensuring safe and effective implantation procedures. Furthermore, neurostimulation devices often require careful programming and adjustments to optimize treatment outcomes, and hospitals have the resources to support these ongoing patient management needs.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest neurostimulation devices market share.

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Latin America (Brazil, Mexico, and Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established healthcare infrastructure and is at the forefront of medical research and technological advancements. The presence of leading healthcare facilities, specialized neurology centers, and renowned research institutions fosters innovation and the adoption of cutting-edge neurostimulation technologies. Moreover, the region has a high prevalence of neurological disorders and chronic pain conditions, leading to a substantial demand for neurostimulation devices for effective management and treatment. The region's aging population, coupled with a growing awareness of neurostimulation therapies among patients and healthcare providers, further fuels market growth. Additionally, favorable reimbursement policies and regulatory frameworks in North America support the widespread adoption of neurostimulation devices.

Competitive Landscape:

Neurostimulation device manufacturers are heavily investing in research and development to enhance their existing products and develop new, innovative technologies. This involves conducting clinical trials, exploring new applications for neurostimulation, and improving the safety and efficacy of their devices. Moreover, companies are introducing new neurostimulation devices or release upgraded versions of existing ones. These launches aim to provide patients and healthcare professionals with state-of-the-art solutions that offer better outcomes and user experiences. Furthermore, companies actively seek to expand their market presence, both geographically and in terms of applications. They may pursue regulatory approvals in different regions, explore new therapeutic areas for neurostimulation, or target specific patient populations with unmet needs. Also, collaboration with other companies, research institutions, and healthcare organizations is common in the neurostimulation devices market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Biocontrol Medical
  • Boston Scientific Corporation
  • Cyberonics Inc.
  • Medtronic Inc.
  • Neuronetics Inc.
  • Neuropace Inc.
  • Neurosigma Inc.
  • Nevro Corporation
  • ST. Jude Medical Inc.
  • Synapse Biomedical Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global neurostimulation devices market in 2025?
  • 2.What is the expected growth rate of the global neurostimulation devices market during 2026-2034?
  • 3.What are the key factors driving the global neurostimulation devices market?
  • 4.What has been the impact of COVID-19 on the global neurostimulation devices market?
  • 5.What is the breakup of the global neurostimulation devices market based on the device type?
  • 6.What is the breakup of the global neurostimulation devices market based on the application?
  • 7.What is the breakup of the global neurostimulation devices market based on the end-user?
  • 8.What are the key regions in the global neurostimulation devices market?
  • 9.Who are the key players/companies in the global neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External Stimulation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Essential Tremors
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Depression
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Dystonia
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Parkinson's Disease
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Post Sales Services

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biocontrol Medical
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boston Scientific Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Cyberonics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Medtronic Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Neuronetics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Neuropace Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Neurosigma Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nevro Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 ST. Jude Medical Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Synapse Biomedical Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2025
  • Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2025
  • Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2025
  • Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
  • Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
  • Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million USD), 2026-2034
  • Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million USD), 2026-2034
  • Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Neurostimulation Devices Market: Competitive Structure
  • Table 8: Global: Neurostimulation Devices Market: Key Players